Astrotech (NASDAQ: ASTC) subsidiary 1st Detect today announced that its new explosives trace detector (ETD), the TRACER 1000, has been accepted into the Transportation Security Administration (TSA)’s Air Cargo Screening Technology Qualification Test (ACSQT) program.
Astrotech (NASDAQ: ASTC) will demonstrate 1st Detect’s mass spectrometry-based explosives and narcotics detector, the TRACER 1000, at Stand 529 at the Border Security Expo (BSE) in San Antonio, TX from Jan. 31st to Feb. 2nd, 2018.
Astrotech (NASDAQ: ASTC) completed a successful 1st Detect demo with DHS and TSA personnel; TRACER 1000 to be demonstrated at their annual meeting of shareholders on Dec. 7th in Austin, TX.
Astrotech (NASDAQ: ASTC) subsidiary 1st Detect has entered into a Cooperative Research and Development Agreement with the DHS S&T Transportation Security Laboratory.
Astrotech (NASDAQ: ASTC) subsidiary 1st Detect, in collaboration with The University of Texas Health Science Center, now called UT Health San Antonio, announced positive preliminary results in pre-clinical trials for the BreathDetect 1000 – a rapid bedside breathalyzer for detecting bacterial infections in the respiratory tract, such as hospital-acquired pneumonia (HAP).